- Home
- Profiles


Robert A Latkany, MD
Ophthalmology (Eye), Cornea, External Disease and Refractive Surgery
- About Me
- Education & Certifications
- Locations
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
About Me
Language
Position
Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
About Me
Language
Position
Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
Education
MD, Boston University School of Medicine
Residency, Ophthalmology
New York Eye & Ear Infirmary
Fellowship, Cornea
New York Eye & Ear Infirmary
Certifications
Ophthalmology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 150 East 32nd Street, Suite 102 - Physician Eyecare of NY, New York, NY, 10016
- Medicare
- NY Medicaid
- 3010 Westchester Avenue, Suite 108, Purchase, NY, 10577
- Medicare
- NY Medicaid
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Recent Artifacts
- Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease results of the randomized phase III OPUS-2 study
- Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)
- Diagnosis of dry eye disease and emerging technologies
- Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye
- Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye
- Retention rate of silicone punctal plugs placed by residents in a general clinic setting
- Dry eyes: Etiology and management
- Chronic epiphora secondary to ocular rosacea
- Comparative evaluation of refractive surgery candidates with Placido topography, Orbscan II, Pentacam, and wavefront analysis
- Prospective evaluation of intraocular lens calculation after myopic refractive surgery
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Latkany is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.